Status:
ACTIVE_NOT_RECRUITING
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)
Lead Sponsor:
Ankara University
Collaborating Sponsors:
Turkish Oncology Group
Conditions:
Biliary Tract Cancer
Biliary Tract Cancers (BTC)
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to compare chemotherapy types that are given after surgery for biliary tract cancers. The main question it aims to answer is: Are any of the chemotherapy regim...
Eligibility Criteria
Inclusion
- Histologically confirmed biliary tract cancer (intrahepatic, perihilar, distal, gallbladder)
- Underwent curative-intent resection
Exclusion
- Patients with a disease without histological confirmation
- Ampullary cancers
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06975917
Start Date
November 1 2024
End Date
May 30 2025
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara University Faculty of Medicine Department of Medical Oncology
Ankara, Turkey (Türkiye)